LaNova Medicines Development Co., Ltd. clinical trials
Acquired by Sino Biopharmaceutical Limited
The registry lists 1 studies whose lead sponsor is LaNova Medicines Development Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 9, 2023.
Registry sponsor names on this page
- LaNova Medicines Development Co., Ltd.1 study
Something wrong with this grouping? Tell us on the Sino Biopharmaceutical Limited page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Sino Biopharmaceutical Limited studies →
- Study of LM-102 in Patients With Advance Solid TumorsTerminatedNCT05008445Phase 1/2
Sponsor listed in the registry: LaNova Medicines Development Co., Ltd. · LaNova Medicines Development Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group